Orlando Immunology Center ( Site 5654) — Orlando, Florida

Public research footprint of Orlando Immunology Center ( Site 5654), compiled from the ClinicalTrials.gov public registry.

159

Registered studies

Active

Recruiting now

121

Completed

Stopped or withdrawn

Most-studied conditions

HIV-1-infection · Pre-Exposure Prophylaxis of HIV Infection · Human Immuno-deficiency Virus (HIV) Disease · Immunologic Deficiency Syndrome, Acquired

Recently updated registry entries

NCT05388474 — A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient… (Completed)
NCT07044297 — A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1)… (Recruiting)
NCT07266831 — A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Orlando Immunology Center ( Site 5654)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.